Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (681-690 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|December 12, 2018
Engineered pH-dependent recycling antibodies enhance elimination of Staphylococcal enterotoxin B superantigen in miceAndrew Kroetsch, Chunxia Qiao, Mairead Heavey, et al.
Mabs|December 12, 2018
Ion channels as therapeutic antibody targetsCatherine J Hutchings, Paul Colussi, Theodore G Clark
Mabs|January 9, 2019
A general platform for antibody purification utilizing engineered-micellesGunasekaran Dhandapani, Assaf Howard, Thien Van Truong, et al.
Mabs|January 15, 2019
Covalent labeling and mass spectrometry reveal subtle higher order structural changes for antibody therapeuticsPatanachai Limpikirati, John E Hale, Mark Hazelbaker, et al.
Mabs|February 14, 2018
Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugatesLily Liu-Shin, Adam Fung, Arun Malhotra, et al.
Mabs|February 14, 2018
Quantitative analysis of glycation and its impact on antigen bindingJingjie Mo, Renzhe Jin, Qingrong Yan, et al.
Mabs|July 22, 2010
Recovery and purification process development for monoclonal antibody productionHui F Liu, Junfen Ma, Charles Winter, et al.
Mabs|July 13, 2010
Cell culture processes for monoclonal antibody productionFeng Li, Natarajan Vijayasankaran, Amy Yijuan Shen, et al.
Mabs|June 29, 2010
Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibodyYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Mabs|June 4, 2010
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allograftsJing Li, Bo Zhou, Jianzhong Shentu, et al.
Pageof 184

Showing results (681-690 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|December 12, 2018
Engineered pH-dependent recycling antibodies enhance elimination of Staphylococcal enterotoxin B superantigen in miceAndrew Kroetsch, Chunxia Qiao, Mairead Heavey, et al.
Mabs|December 12, 2018
Ion channels as therapeutic antibody targetsCatherine J Hutchings, Paul Colussi, Theodore G Clark
Mabs|January 9, 2019
A general platform for antibody purification utilizing engineered-micellesGunasekaran Dhandapani, Assaf Howard, Thien Van Truong, et al.
Mabs|January 15, 2019
Covalent labeling and mass spectrometry reveal subtle higher order structural changes for antibody therapeuticsPatanachai Limpikirati, John E Hale, Mark Hazelbaker, et al.
Mabs|February 14, 2018
Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugatesLily Liu-Shin, Adam Fung, Arun Malhotra, et al.
Mabs|February 14, 2018
Quantitative analysis of glycation and its impact on antigen bindingJingjie Mo, Renzhe Jin, Qingrong Yan, et al.
Mabs|July 22, 2010
Recovery and purification process development for monoclonal antibody productionHui F Liu, Junfen Ma, Charles Winter, et al.
Mabs|July 13, 2010
Cell culture processes for monoclonal antibody productionFeng Li, Natarajan Vijayasankaran, Amy Yijuan Shen, et al.
Mabs|June 29, 2010
Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibodyYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Mabs|June 4, 2010
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allograftsJing Li, Bo Zhou, Jianzhong Shentu, et al.
Pageof 184